SUBSCRIBERS
iX Biopharma to sell Chemical Analysis unit for A$12.5m
Add BT as a preferred source
Vivienne Tay
Published Mon, Feb 18, 2019 · 09:50 PM
Singapore
IX Biopharma has entered into an agreement with independent third party Eurofins Australia New Zealand Holding for the proposed disposal of its entire stake in its wholly owned subsidiary, Chemical Analysis, for A$12.5 million (S$12 million) in cash.
The company expects to receive net proceeds of about S$11.75 million from the sale, after deducting estimated expenses of about S$250,000.
TRENDING NOW
Singapore developer in limbo after Timor-Leste’s shock scrapping of major township project
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
US-China summit: Trump sees ‘better’ ties, Xi warns over Taiwan, as talks conclude
That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think
